Clinical trials: Sclerodactyly
Systemic Sclerosis, Sclerodactyly
Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial
Translational studies have demonstrated reduced hyaluronidase activity in the skin of patients with systemic sclerosis. It is thought this may contribute to the progressive fibrosis seen in this disease.
- Trial name
- HASSc (NCT07697274)
- Testing
- Hyaluronidase (Hylenex)
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Medical University of South Carolina